Envision Pharma Group has acquired medical writing company ProScribe.
Queensland, Australia-based ProScribe provides data dissemination services to academia, biopharmaceutical companies and medical device companies in the Asia-Pacific region.
Envision, headquartered in Southport, Conn., provides technology and scientific communications to pharmaceutical, biotechnology and medical device companies. The acquisition will allow the company to expand into the Asia-Pacific region.
The buyer is backed by Washington, D.C. private equity firm the Halifax Group. Halifax acquired Envision in June.